-- Creative Biolabs, a global leader in biotechnology services, today announced the expansion of its specialized research platforms designed to accelerate the discovery and development of innovative immunotherapies. By integrating expertise in mouse macrophages, complement C1 Inhibitor functional testing, and immortalized cell line modeling, the company is reinforcing its commitment to advancing immune‑based solutions for complex diseases.
Empowering Immunology with Macrophages
Macrophages play a central role in innate immunity, inflammation, and therapeutic response. Creative Biolabs provides comprehensive macrophage products from different species and sources, including polarized M1 and M2 phenotypes..
Customers who use the mouse macrophage bone marrow product speak very highly of it. One customer shared: "These cells saved us the trouble of isolating bone marrow ourselves. The QC report was detailed, and the lot‑to‑lot consistency was impressive. Highly recommended for labs with limited animal resources."
Precision Testing with Complement C1 Inhibitor Assays
The complement system is a critical regulator of immune balance, and dysfunction can lead to severe clinical conditions. Creative Biolabs' complement C1 inhibitor (C1-INH) functional assays deliver sensitive, reproducible results that help researchers evaluate complement activity in both health and disease. By enabling precise measurement of C1‑INH activity, the platform supports therapeutic development for hereditary angioedema (HAE), autoimmune disorders, and other complement‑related pathologies.
"There is no need for any concern regarding the efficiency of project completion. The estimated cycle for completing the C1‑INH functional test typically ranges from 3 to 7 business days, except under special circumstances," said the chief scientist at this company.
Breakthroughs in Immortalized Cell Line Modeling
To bridge immunology and neuroscience, Creative Biolabs has expanded its suite of immortalized cell line models, including neurons, astrocytes, and microglia. These tools are essential for studying neuroinflammation and neurodegenerative diseases.
With long‑term stability, genetic manipulability, and cost‑effectiveness, immortalized cell lines are indispensable for drug screening, gene function studies, and immunotherapy development. By integrating neuroimmune research into its portfolio, Creative Biolabs is helping scientists uncover how immune mechanisms influence brain health and disease progression.
"Our expanded platforms demonstrate our unwavering commitment to advancing immunotherapy research," said a spokesperson for Creative Biolabs. "By combining expertise in people, technology, and platforms, we are equipping researchers with the tools they need to accelerate discovery."
To learn how Creative Biolabs can elevate your work, please explore https://neuros.creative-biolabs.com/.
About Creative Biolabs
Creative Biolabs is a global leader in biotechnology services, specializing in custom solutions for immunology, neuroscience, and therapeutic development. With cutting‑edge platforms and expert teams, the company supports researchers worldwide in achieving scientific breakthroughs that pave the way for innovative therapies.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 17 Ramsey Road, Shirley, NY 11967, USA
Phone: 6318306441
Website: https://neuros.creative-biolabs.com/
Release ID: 89189743
Google
RSS